These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24713450)

  • 21. Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis.
    Shih F; Yip S; McDonald PJ; Chudley AE; Del Bigio MR
    Acta Neuropathol Commun; 2014 Oct; 2():140. PubMed ID: 25330907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychiatric systemic lupus erythematosus in a girl with neurocutaneous melanosis caused by a somatic mutation in NRAS.
    Inoguchi T; Takenouchi T; Yamazaki F; Kondo Y; Mitamura H; Kosaki K; Takahashi T
    Rheumatology (Oxford); 2022 Aug; 61(8):e224-e226. PubMed ID: 35238342
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurocutaneous melanosis.
    Makkar HS; Frieden IJ
    Semin Cutan Med Surg; 2004 Jun; 23(2):138-44. PubMed ID: 15295923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal leptomeningeal melanoma in neurocutaneous melanosis.
    Furtado S; Furtado SV; Ghosal N; Hegde AS
    Pediatr Dermatol; 2012; 29(3):358-61. PubMed ID: 21906139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New aspects of congenital melanocytic nevi].
    Krengel S
    Hautarzt; 2012 Feb; 63(2):82-8. PubMed ID: 22249420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurocutaneous melanosis].
    Mateos González ME; Nieto del Rincón N; Torres Valdivieso MJ; López-Laso E; López Pérez J; Simón de las Heras R; Muñoz MJ; Onsurbe Ramírez I; Lillo Lillo M
    An Esp Pediatr; 2000 Jun; 52(6):573-6. PubMed ID: 11003967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocutaneous melanocytosis-associated malignant melanoma presenting with peritoneal seeding.
    Sener U; Elmore K; Jayaseelan K; Porter J; Marghoob A; Rosenblum MK; Haque S; Khakoo Y
    Pediatr Dermatol; 2021 Sep; 38(5):1298-1301. PubMed ID: 34463389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update.
    Sharouf F; Zaben M; Lammie A; Leach P; Bhatti MI
    Childs Nerv Syst; 2018 Aug; 34(8):1471-1477. PubMed ID: 29948137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AN 11-Year-Old Boy with a Leptomeningeal Tumor.
    Habougit C; Forest F; Boutet C; Douchet C; Stephan JL; Stachowicz ML; Vassal F; Péoc'h M
    Brain Pathol; 2017 Jul; 27(4):553-554. PubMed ID: 28585389
    [No Abstract]   [Full Text] [Related]  

  • 30. Neurocutaneous melanosis presenting with hydrocephalus. Case report and review of the literature.
    Acosta FL; Binder DK; Barkovich AJ; Frieden IJ; Gupta N
    J Neurosurg; 2005 Jan; 102(1 Suppl):96-100. PubMed ID: 16206742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Giant congenital melanocytic nevi: brain magnetic resonance findings in neurologically asymptomatic children.
    Frieden IJ; Williams ML; Barkovich AJ
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):423-9. PubMed ID: 8077466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?
    Patel J; Salgado CM; Múgica MR; Basu D
    Neuro Oncol; 2016 Jan; 18(1):142-3. PubMed ID: 26667139
    [No Abstract]   [Full Text] [Related]  

  • 33. Malignant transformation of neurocutaneous melanosis (NCM) following immunosuppression.
    Schaff LR; Marghoob A; Rosenblum MK; Meyer R; Khakoo Y
    Pediatr Dermatol; 2019 Jul; 36(4):497-500. PubMed ID: 30868657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to "Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?".
    Ruan Y; Narendran A
    Neuro Oncol; 2016 Jan; 18(1):143-4. PubMed ID: 26667140
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurosurgical management of patients with neurocutaneous melanosis: a systematic review.
    Rahman RK; Majmundar N; Ghani H; San A; Koirala M; Gajjar AA; Pappert A; Mazzola CA
    Neurosurg Focus; 2022 May; 52(5):E8. PubMed ID: 35535823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptomatic neurocutaneous melanosis: mild clinical onset in a teenager.
    Vanood A; Lee YA; Leleszi E; Krishnan A
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanoma of the central nervous system based on neurocutaneous melanocytosis in childhood: A rare but fatal condition.
    Abele M; Forchhammer S; Eigentler TK; Popescu A; Maschke L; Lohse J; Lehrnbecher T; Behnisch W; Groll AH; Jakob M; Bernbeck B; Brecht IB; Schneider DT
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30859. PubMed ID: 38225622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocutaneous melanocytosis presenting in a teenager: A case report and review of the literature.
    Monica I; Kumar LP; Uppin MS; Jagannath Rao Naidu KV
    J Cancer Res Ther; 2015; 11(3):649. PubMed ID: 26458618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocutaneous melanomatosis with a rapidly deteriorating course.
    Chu WC; Lee V; Chan YL; Shing MM; Chik KW; Li CK; Ma KC
    AJNR Am J Neuroradiol; 2003 Feb; 24(2):287-90. PubMed ID: 12591651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of neurocutaneous melanosis in Japanese pediatric patients with congenital melanocytic nevi.
    Takiya M; Fushimi Y; Sakamoto M; Yoshida T; Ueno K; Nakajima S; Sakata A; Okuchi S; Otani S; Tagawa H; Morimoto N; Nakamoto Y
    Sci Rep; 2023 Sep; 13(1):16442. PubMed ID: 37777590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.